Introduction: Quilombola communities in the Brazilian Amazon face unique health challenges, including limited access to medical services and exposure to specific risk factors. Assessing cancer risk in these populations is essential for developing prevention and early detection strategies. Objectives: To assess the estimated risk of cancer in a quilombola community in Baixo Tocantins, Pará, using the Q-Cancer questionnaire, and to identify possible differences in risk between sexes. Methods This was a cross-sectional study approved by the research ethics committee of ITPAC Porto Nacional, CAAE 85751624.3.0000.8075, which included members of a quilombola community in the Baixo Tocantins region (PA). Participants answered the Q-Cancer questionnaire, which estimates the risk of various types of cancer based on clinical and demographic factors. Information on age, lifestyle habits (smoking and alcohol consumption) and family history of cancer was collected. Statistical analysis included calculation of means, standard deviations and significance tests for comparison between genders. Results: The mean age was 47.6 years for men and 36.6 years for women (p=0.246). Alcoholism was significantly more prevalent among men (60%) compared to women (0%) (p=0.002). The mean total cancer risk estimated by Q-Cancer was 23.9% for men and 12.6% for women (p=0.701). Men had significantly higher risks for gastroesophageal (4.8% vs. 0.9%; p=0.037), testicular (0.1% vs. 0%; p=0.007) and prostate (0.2% vs. 0%; p=0.007) cancers. Women had significantly higher risks for breast (1.8% vs. 0%; p=0.015), cervical (0.3% vs. 0%; p=0.002), uterine (0.4% vs. 0%; p=0.013) and ovarian (0.3% vs. 0%; p=0.001) cancers. Conclusion: The application of Q-Cancer revealed significant differences in the estimated risk of cancer between men and women in the quilombola community studied, reflecting expected patterns according to sex. The high prevalence of alcoholism among men may contribute to the increased risk of gastrointestinal cancers. These findings highlight the importance of prevention and screening strategies adapted to the cultural and epidemiological specificities of quilombola communities in the Amazon.
It is with great enthusiasm that we present the Annals of the Oncology International Symposium 2025, an event that continues to solidify its significance in the oncology landscape of northern Brazil. Held in Belém, Pará, Oncology 2025 centered around the theme "The cancer control challenge: better knowing it to best facing it," dedicating itself to exploring the latest frontiers in cancer treatment and prevention.
This year, the symposium provided a deep dive into the essential role of knowledge in the fight against cancer, presenting new perspectives and scientific advancements across various areas of oncology. Renowned global experts gathered to share their most recent research and innovative approaches, offering participants a comprehensive view of the challenges faced by healthcare professionals and patients worldwide.
Presentations and discussions during the event focused on critical topics such as the use of new technologies, advancements in personalized therapies, and more effective prevention strategies. Additionally, particular attention was given to the unique challenges faced by the Amazon region, with efforts aimed at developing region-specific solutions to meet local needs.
Beyond being a high-caliber academic event, Oncology 2025 stood out as a moment for integration and professional networking, with the warm hospitality of the city of Belém offering participants a unique experience. This event became a platform for exchanging ideas, where science, culture, and humanity came together in pursuit of a common goal: to improve cancer control both in Brazil and globally.
This collection of abstracts and articles presented during the event reflects the ongoing dedication to research and the development of innovative solutions, highlighting the importance of collaboration and shared knowledge in the fight against cancer.
General Submission Guidelines:
The presenting author, who does not have to be the first author, must be registered for Oncology 2025.
Each abstract may have up to 10 authors, including the main author and co-authors.
Only original, unpublished work will be accepted.
Submissions must be related to oncology. However, project descriptions, work proposals, experience reports, and literature reviews will not be considered.
Clinical case reports are allowed, provided the abstract addresses scientific questions, details clinical observations, and includes primary scientific data.
The abstract must be written in English, but presentations may be given in Portuguese.
Abstracts must be between 300 and 500 words.
Comissão Organizadora
Comissão Científica
See Annals of Oncology 2023 at:
https://www.even3.com.br/anais/oncology-2023-international-symposium/
Complete tool for submission, evaluation and publication of proceedings for scientific events.
